search

Active clinical trials for "Neurasthenia"

Results 1-5 of 5

Internet-based Treatment for Patients Suffering From Severe Functional Somatic Disorders

Bodily Distress Disorder ModerateBodily Distress Disorder Severe4 more

The aim of this multi-center, two-armed, randomized controlled trial is to assess the effect of a novel internet-based therapist-assisted treatment program "One step at a time" designed for the treatment of patients with moderate to severe functional somatic disorders (FSDs). The trial will enroll 166 patients with FSD who will be randomized (1:1) to either the experimental condition (14 weeks' treatment with "One step at a time") or the active control condition ("GetStarted"), which is a non-guided internet-based treatment program for patients with FSD. The trial will include patients aged 18-60 years with an established multi-organ BDS diagnosis with a duration of minimum 6 months. The primary outcome measures will be based on self-reported physical health (SF-36 PPH) and treatment satisfaction (CGI-I). The trial will be considered effective if a higher proportion of patients in the experimental condition report a clinically significant outcome compared with patients in the active control condition at the 3-month follow-up after treatment.

Recruiting11 enrollment criteria

Effectiveness of Mind-Body Interventions for Frequent Attendees Suffering From Medically Unexplained...

NeurastheniaChronic Pain1 more

The purpose of this study is to check the medical efficacy and economic benefits of multidisciplinary care in patients with unexplained medical complaints and consume medical services frequently.

Terminated7 enrollment criteria

Mindfulness-based Cognitive Therapy for Patients With Functional Disorders

Somatization DisorderFunctional Disorders1 more

The aim of the study is to examine the efficacy of Mindfulness-Based Cognitive Therapy (MBCT) in patients with functional disorders defined as severe Bodily Distress Disorder. Hypothesis: MBCT can ameliorate the symptoms of FD defined as severe Bodily Distress Disorder and decrease health care utilization beyond the effect of shared care. Patients treated with MBCT will function better physically and socially than patients treated with shared care at 12 months' follow-up.

Completed10 enrollment criteria

A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia...

AnxietyNeurasthenia1 more

The primary objective of the study is to evaluate the efficacy of Ranquilon, 1 mg tablets, at a dose of 6 mg/day compared to placebo for the treatment of patients with anxiety in neurasthenia and adjustment disorder. An additional study objective was to evaluate the safety of Ranquilon, 1 mg tablets, at a dose of 6 mg/day compared to placebo in patients with anxiety in neurasthenia and adjustment disorder.

Completed51 enrollment criteria

Feasibility and Acceptability of the Internet-delivered Treatment "One Step at the Time" for Bodily...

Bodily Distress Disorder ModerateFibromyalgia3 more

This uncontrolled feasibility pilot study explores the acceptability and potential effect of a 14 week, 11-module, therapist-assisted, internet-delivered treatment program, "One step at the time", for patients moderately affected by Bodily Distress Syndrome. The study includes 25 participants aged 18-60 with multiple functional somatic symptoms for a duration of minimum 6 months. The focus of the feasibility trial is evaluation of treatment response, treatment satisfaction, program utility, recruitment and retention rates, data completion rates, and time requirement. The primary feasibility criterion is a +2.0 points change in patient-rated physical health measured by the SF-36 aggregate score physical health from before to after treatment.

Withdrawn12 enrollment criteria
1

Need Help? Contact our team!


We'll reach out to this number within 24 hrs